Sophie Lachau‐Durand

Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension

Maelíosa T. C. Mc Crudden, Eneko Larrañeta, A. Ruth Clark et al. · Journal of Controlled Release · 2018 · 138 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14

Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates

Olivia Goethals, Suzanne J. F. Kaptein, Bart Kesteleyn et al. · Nature · 2023 · 124 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +15

Absorption, Metabolism, and Excretion of Darunavir, a New Protease Inhibitor, Administered Alone and with Low-Dose Ritonavir in Healthy Subjects

Marc Vermeir, Sophie Lachau‐Durand, Geert Mannens et al. · Drug Metabolism and Disposition · 2009 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Design, Formulation, and Evaluation of Novel Dissolving Microarray Patches Containing Rilpivirine for Intravaginal Delivery

Maelíosa T. C. Mc Crudden, Eneko Larrañeta, A. Ruth Clark et al. · Advanced Healthcare Materials · 2019 · 66 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

2′-Deoxy-2′-spirocyclopropylcytidine Revisited: A New and Selective Inhibitor of the Hepatitis C Virus NS5B Polymerase

Tim H. M. Jonckers, Tse‐I Lin, Christophe Buyck et al. · Journal of Medicinal Chemistry · 2010 · 55 citations

Medicine, Medicinal Chemistry, Pharmacology +17